Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
Viruses · 19.10.2023 · 15 (10) · 2116
DOI: 10.3390/v15102116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 19.10.2023. Verfasst von Swetha Pinninti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human Cytomegalovirus (HCMV) is a ubiquitous member of the Herpesviridae family, responsible for the most common congenital viral infection—congenital Cytomegalovirus (cCMV) infection. While a majority of HCMV infections in children and adults are asymptomatic, HCMV is well known to cause severe infections in the immunocompromised individual and maternal infections with variable long-term sequelae after maternal–fetal transmission with primary or nonprimary infections. HCMV seroprevalence and cCMV incidence vary by geographic area and demographic characteristics like race and socioeconomic status. While cCMV birth prevalence ranges from 0.2% to 6% in different parts of the world, it is influenced by regional HCMV seroprevalence rates. HCMV screening during pregnancy is not routinely offered due to lack of awareness, hurdles to accurate diagnosis, and lack of well-established effective treatment options during pregnancy. This review will focus on antiviral treatment options currently available for use during pregnancy and in the newborn period for the treatment of maternal and congenital HCMV infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
- Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Zitieren
APA
Pinninti, S., & Boppana, S. (2023). Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections. Viruses, 15(10), 2116. https://doi.org/10.3390/v15102116
Vancouver
Pinninti S, Boppana S. Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections. Viruses. 2023;15(10):2116. doi:10.3390/v15102116
BibTeX
@article{Pinninti2023,
author = {Pinninti, Swetha and Boppana, Suresh},
title = {Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections},
journal = {Viruses},
year = {2023},
volume = {15},
number = {10},
pages = {2116},
doi = {10.3390/v15102116}
}
EUVIMED